RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Radius Health - Stock

Radius Health Stocks 2024

Radius Health Stocks

28 M

Ticker

RDUS

ISIN

US7504692077

WKN

A114VH

In 2024, Radius Health had 28 M outstanding stocks, a 0% change from the 28 M stocks in the previous year.

The Radius Health Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2026e28
2026e28
2025e28
2025e28
2024e28
2024e28
202328
202229.5
202129.2
202027.7
201928.2
201828.6
201728.1
201627.2
201527
201427
201326.7
201227.6
201128
201028.1
200928.2
200828.9
200730.4
200630.8
200531.1
200431.1

Radius Health shares outstanding

The number of shares was Radius Health in 2023 — This indicates how many shares 28 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Radius Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Radius Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Radius Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Radius Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Radius Health Aktienanalyse

What does Radius Health do?

Radius Health Inc. is an American pharmaceutical company specializing in the research, development, and marketing of products in the areas of osteoporosis, cancer therapy, and endocrinology. The company was founded in 2003 and is headquartered in Waltham, Massachusetts. The history of Radius Health Inc. began with the discovery of a new compound called Abaloparatide, which was intended for use in the treatment of osteoporosis. The company initiated a Phase III clinical trial to evaluate the efficacy and tolerability of the medication. In 2016, Abaloparatide was approved by the U.S. Food and Drug Administration (FDA) for the treatment of postmenopausal osteoporosis. Since then, Radius Health Inc. has evolved into a leading company specializing in improving women's health. The company has expanded its activities to include oncology and endocrinology and relies on innovative technologies and research to provide better treatment options and medications for patients. The business model of Radius Health Inc. is based on the development and marketing of cost-effective and effective products for the treatment of diseases. The company conducts extensive clinical research and strives to develop new drugs and therapies to improve the lives of women. Radius Health Inc. employs an open and agile corporate culture that promotes innovation and prioritizes the needs of patients. The products offered by Radius Health Inc. include a wide range of medications used in the treatment of osteoporosis, breast cancer, and other diseases. Abaloparatide, the company's flagship product, is a recombinant peptide agonist that stimulates bone formation and reduces the risk of fractures in postmenopausal women. Other products include Elacestrant, an investigative drug for the treatment of breast cancer, and RAD1901, a selective estrogen receptor modulator used in the treatment of hormone-dependent cancers. The company is also active in the field of digital health. Radius Health Inc. has developed an augmented reality app that assists doctors and patients in visualizing bone fractures and other conditions. The app is currently being tested in clinical trials and is expected to be widely used in the future. Overall, Radius Health Inc. is known for its innovative research activities and efforts to improve women's health. The company has an experienced and dedicated team of researchers, scientists, and executives working together to create better treatment options for patients. With a strong pipeline of products and a vision for the future of healthcare, Radius Health Inc. is on track to become a leading provider of medical products and services. Radius Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Radius Health's Shares Outstanding

Radius Health's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Radius Health’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Radius Health’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Radius Health’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Radius Health Stock

How many stocks are there of Radius Health?

The current number of stocks of Radius Health is 28 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Radius Health are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Radius Health evolved in recent years?

The number of shares of Radius Health has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Radius Health as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Radius Health?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Radius Health pay?

Over the past 12 months, Radius Health paid a dividend of 0.75 USD . This corresponds to a dividend yield of about 4.91 %. For the coming 12 months, Radius Health is expected to pay a dividend of 0.86 USD.

What is the dividend yield of Radius Health?

The current dividend yield of Radius Health is 4.91 %.

When does Radius Health pay dividends?

Radius Health pays a quarterly dividend. This is distributed in the months of August, December, March, May.

How secure is the dividend of Radius Health?

Radius Health paid dividends every year for the past 26 years.

What is the dividend of Radius Health?

For the upcoming 12 months, dividends amounting to 0.86 USD are expected. This corresponds to a dividend yield of 5.64 %.

In which sector is Radius Health located?

Radius Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Radius Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Radius Health from 5/6/2024 amounting to 0.188 USD, you needed to have the stock in your portfolio before the ex-date on 4/19/2024.

When did Radius Health pay the last dividend?

The last dividend was paid out on 5/6/2024.

What was the dividend of Radius Health in the year 2023?

In the year 2023, Radius Health distributed 0.75 USD as dividends.

In which currency does Radius Health pay out the dividend?

The dividends of Radius Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Radius Health

Our stock analysis for Radius Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Radius Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.